Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

INTERPRETATION: 6 months of neoadjuvant androgen deprivation combined radiotherapy is an effective treatment option for locally advanced prostate cancer, particularly in men without nodal metastases or pre-existing metabolic comorbidities that could be exacerbated by prolonged androgen deprivation.

via Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial..

 

This study shows that men that are undergoing radiation therapy for prostate cancer had a benefit by adding 6 months of hormonal therapy compared to no hormonal therapy.

Added Radiation to ADT May Improve Survival – Renal and Urology News

Men with locally advanced prostate cancer (PCa) have a better chance of survival when they add radiation therapy (RT) to their hormone therapy, according to research presented at the 52nd annual meeting of the American Society for Radiation Oncology.

via Added Radiation to ADT May Improve Survival – Renal and Urology News.

This is another study that finds a survival advantage in adding radiation therapy to hormonal therapy in advanced prostate cancer.  Traditionally, urologists treated these patients with hormonal therapy only since radiation was not curative.

Newer studies are showing that external beam radiation added to hormonal therapy helps people live longer.  I think this is because radiation therapy is safer than it was in the past and treating the primary tumor may help prevent future metastases.

Search

+